Review of medical abortion using mifepristone in combination with a prostaglandin analogue

被引：101

作者：

Fiala, Christian

Gemzell-Danielsson, Kristina

机构：

[1] Gynmed Clin, A-1150 Vienna, Austria

[2] Karolinska Inst, Div Obstet & Gynaecol, Dept Woman & Child Hlth, SE-17176 Stockholm, Sweden

来源：

CONTRACEPTION | 2006年 / 74卷 / 01期

关键词：

medical abortion; mifepristone; misoprostol; gemeprost; review;

D O I：

10.1016/j.contraception.2006.03.018

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Induced abortion is still a major health problem in the world and the most frequently performed intervention in obstetrics and gynecology with an estimated total of 46 million worldwide each year. Medical abortion with mifepristone and prostaglandin was first introduced in 1988 and is now approved in 31 countries. This combination of drugs has recently been included in the List of Essential Medicines by the World Health Organisation. The present review summarizes the development, physiology and the development of the currently used regimens. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：66 / 86

页数：21

共 200 条

[21] Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation [J].